2nd Quarter - Report

MEDIMMUNE, LLC. for MEDIMMUNE LLC

Firm
Client
Income
—
Expenses
$200,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

House Tri-Committee healthcare reform bill: follow-on biologics; Medicaid Rebate, School-based seasonal influenza vaccinations Supplemental Appropriations: HINI Funding for vaccine R&D H.R. 2596, the No Child Left Unimmunized Against Influenza Act: All provisions H.R. 5629 Pathway for Biosimilars Act: All Provisions The Affordable Health Choice Act: Provisions impacting a regulatory pathway for follow-on biologics Senate Finance healthcare reform bill yet to be introduced: Provisions impacting the Medicaid rebate Pandemic Preparation Act of 2009 - All provisions.

Foreign entity interest: As the ultimate parent of MedImmune, LLC., Astra Zenenca PLC, has interests in the issues lobbied.

LobbyistCovered position, as disclosed
VANESSA PROCTER —
BRIAN M ROSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2596 (111th), H.R. 5629 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.